Filing Flows › DocuSign (DOCU) › R&D spending
DocuSign (DOCU) R&D spending by quarter
DocuSign's R&D spending was $164M in Q2 FY27 (second quarter fiscal 2027), +3% from Q1 FY27. Over the last 7 quarters it ranged from $155M (Q4 FY25) to $170M (Q2 FY26).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q2 FY27 | $164M | +3% | -4% |
| Q1 FY27 | $160M | -5% | +0.1% |
| Q4 FY26 | $168M | +0.4% | +8% |
| Q3 FY26 | $168M | -1% | — |
| Q2 FY26 | $170M | +6% | — |
| Q1 FY26 | $159M | +3% | — |
| Q4 FY25 | $155M | — | — |
Q2 FY27 at a glance
DocuSign, Q2 FY27: revenue $876M (+9% year over year), operating margin 13.4%, net earnings $77.7M, operating cash flow $335M. The chart follows the revenue to costs, profit and cash.
Questions
What is DocuSign's R&D spending?
DocuSign's R&D spending was $164M in Q2 FY27 (second quarter fiscal 2027), +3% from Q1 FY27.
How has DocuSign's R&D spending changed?
Over the last 7 quarters it ranged from $155M (Q4 FY25) to $170M (Q2 FY26).